**REGISTERED CHARITY NUMBER: 505256**
**Report of the Trustees and**
**Unaudited Financial Statements**
**for the Year Ended 30 April 2024**
## **for**
## **Kidneys For Life**
Paterson Brodie Limited Chartered Certified Accountants Cliveden Chambers Cliveden Place Longton Stoke-on-Trent Staffordshire ST3 4JB
**Kidneys For Life**
## **Contents of the Financial Statements for the Year Ended 30 April 2024**
|||**Page**||
|---|---|---|---|
|**Report of the Trustees**|1|to|5|
|**Independent Examiner's Report**||6||
|**Statement of Financial Activities**||7||
|**Balance Sheet**|8|to|9|
|**Notes to the Financial Statements**|10|to|22|
|**Detailed Statement of Financial Activities**|23|to|24|
**Kidneys For Life**
## **Report of the Trustees for the Year Ended 30 April 2024**
The trustees present their report with the financial statements of the charity for the year ended 30 April 2024. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
## **OBJECTIVES AND ACTIVITIES**
## **Our mission**
The strategic aim of Kidneys for Life fundraising for MINT (Manchester Institute for Nephrology & Transplantation) is the relief of renal related illnesses and the funding of research and education in renal disease, transplantation and allied fields together with the provision of direct patient amenities.
## **Objectives**
Kidneys for Life's objectives and main activities are to undertake charitable fundraising and the provision of those funds for the research and education in renal disease and allied fields and the provision of direct patient amenities.
The trustees confirm that they have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the Trust's aims and objectives and in planning future activities and setting the grant making policy for the year.
## **Significant activities**
The main activities currently carried out for the public benefit by the charity can be broadly categorised into the following:-
- Research into renal related disease and associated diseases including transplantation
- Direct patient amenities for those renal patients at Manchester Royal Infirmary, Royal Manchester Children's Hospital and Salford Royal Infirmary and their outlying satellite dialysis units
The beneficiaries of our main activities are ultimately sufferers of renal related diseases and those at risk of developing this disease in the future together with their families/carers. There are increasing numbers of people in the UK with some form of kidney disease and this is on the rise due to increased life expectancy and less healthier lifestyles. Developments in the care and treatment of those suffering from kidney disease has also the potential to relieve the huge burden of care often faced by the families and/or carers of sufferers. Our research and educational programmes funds researchers and renal staff who use these funds in their work to improve the lives of sufferers from kidney disease and related conditions, and their carers by developing therapies, potential medications and improvements in the personal care of sufferers. Any benefit received by researchers is purely incidental to the objects of our work.
MINT is a member of the Association of Medical Research Charities and follows best practice in maintaining the independence of research funding and ensuring that sponsored researchers abide by best practice in research ethics and animal testing; our aim is to maximise the efficiency of the research programme whilst minimising the likelihood of harm to research volunteers and animals.
## **How we work**
The charity delivers its main aims in a number of ways including:-
- Small Research Grants Scheme relating to renal diseases and transplantation
- Post doctorate grants into renal disease and transplantation
- Travel bursaries for renal staff to attend specialised training courses to further enhance their knowledge of renal diseases and transplantation
- Educational grants to renal staff
- Support for specialist conferences both in the UK and overseas including the Fabry Nephropathy Conference which took place in Hamburg in 2024 and is due to take place again in 2026. The venue for the 2026 Update is still to be confirmed.
Academic ability and research potential are the primary determinants of our bursaries and grants and other factors
Page 1
**Kidneys For Life**
## **Report of the Trustees for the Year Ended 30 April 2024**
## **OBJECTIVES AND ACTIVITIES**
such as nationality, ethnicity, gender, age, disability, sexual orientation and religion will not be taken into account. In addition to this the charity also funds direct patient amenities for those suffering from renal disease or related diseases and this provision is not dependent upon factors such as nationality, ethnicity, gender, age, disability, sexual orientation and religion.
## **ACHIEVEMENT AND PERFORMANCE Review of our achievements this financial year**
The benefits of the charities work is the research into renal related diseases, education of renal staff, the dissemination of research findings, the development of new therapies and the funding of on-going research with the goal being to assist sufferers of renal related diseases, their carers and families. The trustees are pleased that the achievements and performance of the Charity as set out below with more detail on expenditure items, demonstrate our commitment to relieving the suffering of those with renal related diseases:-
Research Grant round 2023 - as with previous years, we invited applications for small research grants (to the value of £10000). Interest in the applications was very high and we were delighted to receive 19 grant applications. Following Trustee review we provided funding to the value of £46,103 (5 projects). Details of all projects can be found on our website - https://kidneysforlife.org/our-research/research-projects/
Our Research Grants are paid in arrears the total of outstanding grants is £119,318.
In the last financial year, we paid £57,740 to our Research Projects with the breakdown as follows:
- £2,229 was spent on Research Grant 2021 -Treating a genetic kidney disease in a human stem cell
- £3,284 was spent on Research Grant 2022 - Combining Spatial Transcriptomics and Hyperion Imaging Flow
- Cytometry to identify therapeutic targets in human Diabetic kidney disease
- £4,500 was spent on Research Grant 2022 - Relevance of Non-HLA Antibodies in Kidney Transplantation
- £4,960 was spent on Research Grant 2021 - Improving the accuracy of chronic kidney disease monitoring using postal finger prick iohexol measured GFR
- £5,487 was spent on Research Grant 2022 - Pinpointing where kidney and lower urinary tract malformation genes are expressed in human development
- £8,200 was spent on Research Grant 2022 - MANVAS (Manchester Vascular Access Study)
- £8,650 was spent on Research Grant 2019 - Validation of cystatin for GFR estimation in older patients with CF
- £9,510 was spent on Research Grant 2022 - Long-term efficacy of gene therapy for an early onset bladder disease
- £10,920 was spent from the Bladder Exstrophy Fund for the bladder patch study
- We contributed £ 9,961 for patient amenities.
- We contributed £2,007 to support a variety of other miscellaneous grants.
- We made awards to help fund further education of renal nursing staff totalling £5,057. Courses that the nurses attended included a Two-day Frailty education course which helped in the redesign of Renal Supportive care clinic; the National Organ Retrieval Service Cadaveric Retrieval Masterclass and UK Annual Dialysis Conference.
- We provided travel grant bursaries to the value of £5,331.
- We made a contribution of £23,166 towards the Manchester Children's Transplant Team in 2023 for their attendance at the British Transplant Games in Coventry.
- We made a contribution of £1,594 to the Urology Sports Day. This is a fully inclusive event which is hosted at the Regional Sports Arena in Manchester. All families with children under the care of the Urology department at RMCH receive an invite. The event is free to attend and there are a variety of sporting activities available to try on the day; the aim of the event is to empower the children to try new activities whilst also giving families the chance to network with others who have similar lived experiences.
Details of all research projects can be found on our website and further information can be provided by contacting the charity directly.
Page 2
## **Kidneys For Life**
## **Report of the Trustees for the Year Ended 30 April 2024**
## **FINANCIAL REVIEW**
## **Results**
The total incoming resources for the year amount to £213,306 (2023 the figure was £308,130). The charity expenditure for the financial year was £251,946 (2023 figure was £292,025).
The current market value of the KFL investment portfolio at the year-end was £289,093.
We were beneficiaries of a generous legacy donation from a longstanding and loyal supporter of Kidneys for Life. We also received significant income from funeral donations.
Whilst our expenditure on travel grants increased from the year-end 2023 (£2,574) we note that it is still lower than pre-Covid. With conferences now taking place and less access to funding from within the NHS, we expect numerous travel grant requests for the coming year. This is also the case for Nurse Education grants where again our expenditure has increased from year-end 2023 (£2,054).
We are pleased with the feedback from those who have attended conferences and training courses of the impact and benefit their learning will have for renal patients.
Whilst income was steady and from varied income streams, we did see a significant decrease in overall income in comparison with the previous year. There was no headline fundraising event for this financial year and the focus was placed on supporting individuals to fundraise for the charity. For future years, we intend to host a KFL event whilst also encouraging and supporting fundraisers to generate income and awareness of the charity. We believe this approach will be in the best interest of Kidneys for Life and will ensure we generate enough income to sustain, and with time, increase the range of our charitable activities.
## **Investment policy and financial position**
The charity has the power to make any investment which the Trustees see fit. Our investments are managed by Redmayne Bailey and we receive quarterly reports on the value of the Kidneys for Life portfolio. The spread of investments was agreed and a certain approach to risk continued. The charity believes it can generate income which together with investment income will allow the charity to continue for the foreseeable future with its level of charitable payments.
## **Reserves policy**
The events of recent years have had an effect upon the reserves of the Charity and the Trustees are aware that it will be imperative that we maintain income to ensure that we are able to have in reserves funding for one year for our Travel Bursaries, Nurse Education Grants, Publication Grants & Small Research Grants Scheme, £200k approximately. We endeavour to spend in excess of our income, save for restricted funds as detailed in Note 14, leaving sufficient reserves to fund ongoing research as mentioned.
## **FUTURE PLANS**
We will continue to carry out our main activities and our focus on future research, which by its nature is a slow process. Our focus will be:
- to improve diagnosis and treatments for patients with kidney inflammation ( to stop progression to kidney failure) - to improve the treatment for patients on dialysis at home and in hospital dialysis units looking at improving phosphate and sodium clearance and water balance
- to improve the lifespan of kidney transplants through clinical trials of new drugs and by preventing graft loss from recurrence of the primary kidney disease in the transplant
## **STRUCTURE, GOVERNANCE AND MANAGEMENT**
## **Governing document and legal status**
The trust is governed by a trust deed dated 6th May 1976 and supplemental deeds of 15th September 1977 and 1st September 1983 and resolution of 4th August 1997, with the scheme further amended on 10th May 2000, 12 July 2007, 11th December 2015, 19th July 2019 and 22nd November 2019.
## **Recruitment and appointment of new trustees**
A trustee can propose the appointment of a trustee, on a proposal a vote shall be taken and approval shall be obtained through a simple majority.
Page 3
**Kidneys For Life**
## **Report of the Trustees for the Year Ended 30 April 2024**
## **STRUCTURE, GOVERNANCE AND MANAGEMENT**
## **Organisation**
The charity is administered from the Renal Unit at Manchester Royal Infirmary. The charity's objects and principal activity consists of charitable fundraising and the provisions of those funds for the advancement of research and provision of direct patient amenities for those suffering from kidney related diseases.
Our trustees are unpaid and details of trustee expenses and any related party transactions are disclosed in note 5 to the accounts.
## **Decision making**
All decisions are made by a consensus of the Trustees who are all Renal Consultants in the North-West of England.
## **Trustee induction, training and development**
New trustees are provided with an induction pack and are given initial training by the trustees and further training as and when required.
## **Risk management**
The Trustees review the major risks which the Charity faces at Trustee meetings. Trustee meetings take place three times per year and will continue to do so going forward. In addition to this the Trustees will convene additional meetings to discuss the financial position of the Charity. It is anticipated that by reviewing on a regular basis the Trustees will be able to appropriately adjust the reserves and charitable payments in line with the performance of the Charity. This will allow for the Trustees to provide sufficient resources in the event of adverse conditions. The Trustees have also examined other operational and business risks faced by the Charity and confirm that they have established systems to mitigate the immediate significant risks.
## **REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number**
505256
## **Principal address**
Renal Unit Manchester Royal Infirmary Oxford Road Manchester M13 9WL
## **Trustees**
|**Trustees**|||
|---|---|---|
|Professor Titus Augustine|Consultant Surgeon|Resigned 19th May 2023|
|Professor Rachel Lennon|Consultant Paediatric Physician||
|Professor Sandip Mitra|Consultant Physician||
|Mr Afshin Tavakoli|Consultant Surgeon||
|Professor Phil Kalra|Consultant Physician|Resigned 5th October 2024|
|Dr Durga Kanigicherla|Consultant Nephrologist||
|Dr Amrit Kaur|Consultant in Paediatric Nephrology||
|Professor Smeeta Sinha|Consultant Nephrologist||
|Dr Andrew Nixon|Consultant Nephrologist|Appointed 19th May 2023|
|Dr Ajay Dhaygude|Consultant Renal Physician|Appointed 19th May 2023|
Page 4
**Kidneys For Life**
## **Report of the Trustees for the Year Ended 30 April 2024**
**REFERENCE AND ADMINISTRATIVE DETAILS Independent Examiner** Paul Scriven FCCA Paterson Brodie Limited Chartered Certified Accountants Cliveden Chambers Cliveden Place Longton Stoke-on-Trent Staffordshire ST3 4JB
Approved by order of the board of trustees on 24 January 2025 and signed on its behalf by:
Mr Afshin Tavakoli - Trustee
Page 5
## **Independent Examiner's Report to the Trustees of Kidneys For Life**
## **Independent examiner's report to the trustees of Kidneys For Life**
I report to the charity trustees on my examination of the accounts of Kidneys For Life (the Trust) for the year ended 30 April 2024.
## **Responsibilities and basis of report**
As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').
I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5)(b) of the Act.
## **Independent examiner's statement**
I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:
1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Paul Scriven FCCA
Paterson Brodie Limited Chartered Certified Accountants Cliveden Chambers Cliveden Place Longton Stoke-on-Trent Staffordshire ST3 4JB
24 January 2025
Page 6
## **Kidneys For Life**
## **Statement of Financial Activities**
## **for the Year Ended 30 April 2024**
|Unrestricted
funds
Notes
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
2
119,866
Other trading activities
3
51,340
Investment income
4
3,760
Other income
254
**Total**
175,220
**EXPENDITURE ON**
Raising funds
75,519
**Charitable activities**
Expenditure on Charitable Activities
130,152
**Total**
205,671
Net gains/(losses) on investments
24,809
**NET INCOME/(EXPENDITURE)**
(5,642)
**Transfers between funds**
14
26,182
**Net movement in funds**
20,540
**RECONCILIATION OF FUNDS**
Total funds brought forward
101,259
**TOTAL FUNDS CARRIED FORWARD**
121,799|Restricted
funds
£
19,865
17,404
78
739
38,086
6,666
39,609
46,275
-
(8,189)
(26,182)
(34,371)
228,677
194,306|30.4.24
Total
funds
£
139,731
68,744
3,838
993
213,306
82,185
169,761
251,946
24,809
(13,831)
-
(13,831)
329,936
316,105|30.4.23
Total
funds
£
138,777
164,632
3,238
1,483
308,130
131,359
160,666
292,025
(26,170)
(10,065)
-
(10,065)
340,001
329,936|
|---|---|---|---|
## **CONTINUING OPERATIONS**
All income and expenditure has arisen from continuing activities.
The notes form part of these financial statements
Page 7
## **Kidneys For Life**
## **Balance Sheet 30 April 2024**
|Unrestricted
funds
Notes
£
**FIXED ASSETS**
Investments
10
115,927
**CURRENT ASSETS**
Stocks
11
2,806
Debtors
12
5,588
Cash at bank and in hand
19,326
27,720
**CREDITORS**
Amounts falling due within one year
13
(21,848)
**NET CURRENT ASSETS**
5,872
**TOTAL ASSETS LESS CURRENT**
**LIABILITIES**
121,799
**NET ASSETS**
121,799|Restricted
funds
£
173,166
-
200
34,635
34,835
(13,695)
21,140
194,306
194,306|30.4.24
Total
funds
£
289,093
2,806
5,788
53,961
62,555
(35,543)
27,012
316,105
316,105|30.4.23
Total
funds
£
263,357
3,274
7,245
119,216
129,735
(63,156)
66,579
329,936
329,936|
|---|---|---|---|
The notes form part of these financial statements
continued...
Page 8
## **Kidneys For Life**
## **Balance Sheet - continued 30 April 2024**
|||||30.4.24|30.4.23|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||funds|funds|funds|funds|
||Notes|£|£|£|£|
|**FUNDS**|14|||||
|Unrestricted funds:||||||
|General fund||||107,719|88,468|
|Revaluation Fund||||14,080|12,791|
|||||121,799|101,259|
|Restricted funds:||||||
|Children's Renal Fund||||40,428|59,966|
|Bladder Exstrophy Fund||||18,346|19,970|
|Grants Awarded Not Yet Taken||||119,318|135,500|
|Kidney Info Network||||291|287|
|Urology Sports Day||||5,651|4,642|
|Tameside Dialysis||||3,729|4,007|
|Adult Transplant Games||||2,000|-|
|Polycystic kidney disease research||||1,998|1,998|
|Cheshire and Merseyside Kidney Information||||845|845|
|network Recipe||||||
|Altrincham Dialysis unit||||515|935|
|Bladder Exstrophy Xmas Party||||756|527|
|MRIKPA||||||
|||||429|-|
|||||194,306|228,677|
|||||||
|**TOTAL FUNDS**||||316,105|329,936|
The financial statements were approved by the Board of Trustees and authorised for issue on 24 January 2025 and were signed on its behalf by:
Mr Afshin Tavakoli - Trustee
Dr Amrit Kaur - Trustee
The notes form part of these financial statements
Page 9
**Kidneys For Life**
## **Notes to the Financial Statements for the Year Ended 30 April 2024**
## **1. ACCOUNTING POLICIES**
## **Basis of preparing the financial statements**
The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention, with the exception of investments which are included at market value, as modified by the revaluation of certain assets.
## **Financial reporting standard 102 - reduced disclosure exemptions**
The charity has taken advantage of the following disclosure exemption in preparing these financial statements, as permitted by FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland':
- the requirements of Section 7 Statement of Cash Flows.
## **Income**
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.The following specific policies are applied to particular categories of income:
Voluntary income is received by way of grants, donations and gifts and is included in full in the statement of financial activities when receivable. Grants, where entitlement is not conditional on the delivery of a specific performance by the charity are recognised when the charity becomes unconditionally entitled to the grant.
Investment income is included when receivable.
Fundraising events income includes all income from both Kidneys for Life led events and those undertaken by supporters.
## **Expenditure**
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Expenditure includes any irrecoverable VAT which cannot be fully recovered and is charged against the expenditure to which it relates. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
Cost of raising funds comprise of the costs associated with attracting voluntary income and the costs of trading for fundraising purposes.
Charitable expenditure comprise of those costs incurred by the charity in the delivering of its activities and providing grants.
Governance costs include those costs associated with the constitutional and statutory requirements of the Charity and include the accountancy fee and other overhead and support costs.
## **Tangible fixed assets**
Fixed assets (excluding investments) are stated at cost less accumulated depreciation. The costs of minor additions or those costing below £1,000 are not capitalised. Depreciation is provided at rates calculated to write off the cost of each asset over its expected useful life, which in all cases is estimated at 5 years.
continued...
Page 10
**Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
## **1. ACCOUNTING POLICIES - continued**
## **Stocks**
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.
## **Taxation**
The charity is exempt from tax on its charitable activities.
## **Fund accounting**
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees. Unrestricted funds include a revaluation reserve representing the restatement of investment assets at current value.
Designated funds are unrestricted funds earmarked by the management committee for particular purposes.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or through the terms of an appeal.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
## **Pension costs and other post-retirement benefits**
The Charity operates a defined contribution pension scheme. Contributions payable to the pension scheme are charged to the Statement of Financial Activities in the period to which they relate.
## **2. DONATIONS AND LEGACIES**
|Donations
Legacies
Grants|30.4.24
£
109,106
26,625
4,000
139,731|30.4.23
£
134,150
-
4,627|
|---|---|---|
|||138,777|
Donations includes £15,865 (2023 - £12,038) relating to the restricted funds for Bladder Exstrophy, Bladder Exstrophy Xmas Party, Children's Renal Fund (formerly Child Transplant Games), Tameside Dialysis, Urology Sports Day, MRIKPA and Adult Transplant Games.
Grants received, included in the above, are as follows:
||30.4.24|30.4.23|
|---|---|---|
||£|£|
|Other grants|4,000|4,627|
continued...
Page 11
**Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
## **3. OTHER TRADING ACTIVITIES**
|**OTHER TRADING ACTIVITIES**|||
|---|---|---|
||30.4.24|30.4.23|
||£|£|
|Fundraising events|68,744|164,632|
Fundraising includes £17,404 (2023 - £19,880) relating to the restricted funds for Children's Renal Fund (formerly Child Transplant Games), Bladder Exstrophy and Urology Sports Day.
## **4. INVESTMENT INCOME**
|**INVESTMENT INCOME**|||
|---|---|---|
||30.4.24|30.4.23|
||£|£|
|Dividend and stock income|2,920|2,720|
|Deposit account interest|918|518|
||3,838|3,238|
## **5. TRUSTEES' REMUNERATION AND BENEFITS**
There were no trustees' remuneration or other benefits for the year ended 30 April 2024 nor for the year ended 30 April 2023.
## **Trustees' expenses**
There were no trustees' expenses paid during the year ended 30 April 2024 nor for the year ended 30 April 2023.
## **6. STAFF COSTS**
The average monthly number of employees during the year was as follows:
||30.4.24|30.4.23|
|---|---|---|
|Staff|1|1|
No employees received emoluments in excess of £60,000.
## **7. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES**
|Unrestricted
funds
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
122,112
Other trading activities
144,752
Investment income
3,236
Other income
633
**Total**
270,733
**EXPENDITURE ON**
Raising funds
121,406
**Charitable activities**
Expenditure on Charitable Activities
77,649|Restricted
funds
£
16,665
19,880
2
850
37,397
9,953
83,017|Total
funds
£
138,777
164,632
3,238
1,483|
|---|---|---|
|||308,130|
|||131,359
160,666|
continued...
Page 12
## **Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
|**7.**
**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued**
Unrestricted
Restricted
funds
funds
£
£
**Total**
199,055
92,970
Net gains/(losses) on investments
(26,170)
-
**NET INCOME/(EXPENDITURE)**
45,508
(55,573)
**Transfers between funds**
(36,789)
36,789
**Net movement in funds**
8,719
(18,784)
**RECONCILIATION OF FUNDS**
Total funds brought forward
92,540
247,461
**TOTAL FUNDS CARRIED FORWARD**
101,259
228,677
**8.**
**NET GAINS/(LOSSES) ON INVESTMENTS**
Realised net gains on investments
30.4.24
£
Share dealing - gains
25,196
Share dealing - losses
(2,986)
22,210
Unrealised (loss)/gain on revaluation
2,599
24,809
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
495|**7.**
**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued**
Unrestricted
Restricted
funds
funds
£
£
**Total**
199,055
92,970
Net gains/(losses) on investments
(26,170)
-
**NET INCOME/(EXPENDITURE)**
45,508
(55,573)
**Transfers between funds**
(36,789)
36,789
**Net movement in funds**
8,719
(18,784)
**RECONCILIATION OF FUNDS**
Total funds brought forward
92,540
247,461
**TOTAL FUNDS CARRIED FORWARD**
101,259
228,677
**8.**
**NET GAINS/(LOSSES) ON INVESTMENTS**
Realised net gains on investments
30.4.24
£
Share dealing - gains
25,196
Share dealing - losses
(2,986)
22,210
Unrealised (loss)/gain on revaluation
2,599
24,809
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
495|**7.**
**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued**
Unrestricted
Restricted
funds
funds
£
£
**Total**
199,055
92,970
Net gains/(losses) on investments
(26,170)
-
**NET INCOME/(EXPENDITURE)**
45,508
(55,573)
**Transfers between funds**
(36,789)
36,789
**Net movement in funds**
8,719
(18,784)
**RECONCILIATION OF FUNDS**
Total funds brought forward
92,540
247,461
**TOTAL FUNDS CARRIED FORWARD**
101,259
228,677
**8.**
**NET GAINS/(LOSSES) ON INVESTMENTS**
Realised net gains on investments
30.4.24
£
Share dealing - gains
25,196
Share dealing - losses
(2,986)
22,210
Unrealised (loss)/gain on revaluation
2,599
24,809
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
495|**7.**
**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued**
Unrestricted
Restricted
funds
funds
£
£
**Total**
199,055
92,970
Net gains/(losses) on investments
(26,170)
-
**NET INCOME/(EXPENDITURE)**
45,508
(55,573)
**Transfers between funds**
(36,789)
36,789
**Net movement in funds**
8,719
(18,784)
**RECONCILIATION OF FUNDS**
Total funds brought forward
92,540
247,461
**TOTAL FUNDS CARRIED FORWARD**
101,259
228,677
**8.**
**NET GAINS/(LOSSES) ON INVESTMENTS**
Realised net gains on investments
30.4.24
£
Share dealing - gains
25,196
Share dealing - losses
(2,986)
22,210
Unrealised (loss)/gain on revaluation
2,599
24,809
Realised net losses/gains are stated after deducting dealing charges.
Total transaction charges for the year are as follows:
£
Dealing charges
495||Total
funds
£
292,025
(26,170)
(10,065)
-
(10,065)
340,001
329,936
30.4.23
£
1,346
(1,027)
319
(26,489)
(26,170)
£
70|
|---|---|---|---|---|---|
||||30.4.24|||
||||£|||
||||25,196|||
||||(2,986)|||
|||||||
|||||||
||||22,210|||
||||2,599|||
|||||||
|||||||
||||24,809|||
|||||||
|||||||
|||||||
||||£|||
||||495|||
|||||||
|||||||
continued...
Page 13
## **Kidneys For Life**
## **Notes to the Financial Statements - continued**
## **for the Year Ended 30 April 2024**
## **9. TANGIBLE FIXED ASSETS**
|**TANGIBLE FIXED ASSETS**||
|---|---|
|Office
Computer
equipment
equipment
£
£
**COST**
At 1 May 2023
1,518
13,535
Disposals
-
(13,535)
At 30 April 2024
1,518
-
**DEPRECIATION**
At 1 May 2023
1,518
13,535
Eliminated on disposal
-
(13,535)
At 30 April 2024
1,518
-
**NET BOOK VALUE**
At 30 April 2024
-
-
At 30 April 2023
-
-|Totals
£
15,053
(13,535)|
||1,518|
||15,053
(13,535)|
||1,518|
||-|
||-|
## **10. FIXED ASSET INVESTMENTS**
Fixed asset investments consist of the Kidneys for Life Portfolio. The Portfolio is valued at current market value at the year end date
## **11. STOCKS**
|**11.**|**STOCKS**|||
|---|---|---|---|
|||30.4.24|30.4.23|
|||£|£|
||Finished goods|2,806|3,274|
|**12.**|**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**|||
|||30.4.24|30.4.23|
|||£|£|
||Trade debtors|454|633|
||Other debtors|3,113|4,722|
||Prepayments|2,221|1,890|
|||5,788|7,245|
continued...
Page 14
## **Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
## **13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
||30.4.24|30.4.23|
|---|---|---|
||£|£|
|Trade creditors|23,627|2,641|
|Taxation and social security|237|96|
|Other creditors|11,679|60,419|
||35,543|63,156|
## **14. MOVEMENT IN FUNDS**
|**Unrestricted funds**
General fund
Revaluation Fund
Designated Fund
**Restricted funds**
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney
Information network Recipe
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
MRIKPA
**TOTAL FUNDS**|At 1.5.23
£
88,468
12,791
-
101,259
59,966
19,970
135,500
287
4,642
4,007
-
1,998
845
935
527
-
228,677
329,936|Net
movement
in funds
£
11,189
2,599
(19,430)
(5,642)
(9,538)
(1,624)
-
4
1,009
(278)
2,000
-
-
(420)
229
429
(8,189)
(13,831)|Transfers
between
funds
£
8,062
(1,310)
19,430
26,182
(10,000)
-
(16,182)
-
-
-
-
-
-
-
-
-
(26,182)
-|At
30.4.24
£
107,719
14,080
-|
|---|---|---|---|---|
|||||121,799
40,428
18,346
119,318
291
5,651
3,729
2,000
1,998
845
515
756
429|
|||||194,306|
|||||316,105|
Page 15
continued...
**Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
## **14. MOVEMENT IN FUNDS - continued**
Net movement in funds, included in the above are as follows:
|**Unrestricted funds**
General fund
Revaluation Fund
Designated Fund
**Restricted funds**
Children's Renal Fund
Bladder Exstrophy Fund
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
MRIKPA
**TOTAL FUNDS**|Incoming
resources
£
175,220
-
-
175,220
19,903
10,440
4
2,800
1,120
2,000
-
1,032
787
38,086
213,306|Resources
expended
£
(186,241)
-
(19,430)
(205,671)
(29,441)
(12,064)
-
(1,791)
(1,398)
-
(420)
(803)
(358)
(46,275)
(251,946)|Gains and
Movement
losses
in funds
£
£
22,210
11,189
2,599
2,599
-
(19,430)
24,809
(5,642)
-
(9,538)
-
(1,624)
-
4
-
1,009
-
(278)
-
2,000
-
(420)
-
229
-
429
-
(8,189)
24,809
(13,831)|
|---|---|---|---|
Page 16
continued...
**Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
## **14. MOVEMENT IN FUNDS - continued**
## **Comparatives for movement in funds**
|**Unrestricted funds**
General fund
Revaluation Fund
Designated Fund
**Restricted funds**
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney
Information network Recipe
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
**TOTAL FUNDS**|At 1.5.22
£
53,260
39,280
-
92,540
69,071
20,452
149,416
285
3,792
1,102
1,000
1,998
345
-
-
247,461
340,001|Net
movement
in funds
£
83,841
(26,489)
(11,844)
45,508
(9,105)
355
(50,705)
2
850
2,905
(1,000)
-
500
935
(310)
(55,573)
(10,065)|Transfers
between
funds
£
(48,633)
-
11,844
(36,789)
-
(837)
36,789
-
-
-
-
-
-
-
837
36,789
-|At
30.4.23
£
88,468
12,791
-|
|---|---|---|---|---|
|||||101,259
59,966
19,970
135,500
287
4,642
4,007
-
1,998
845
935
527|
|||||228,677|
|||||329,936|
continued...
Page 17
**Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
## **14. MOVEMENT IN FUNDS - continued**
Comparative net movement in funds, included in the above are as follows:
|**Unrestricted funds**
General fund
Revaluation Fund
Designated Fund
**Restricted funds**
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Cheshire and Merseyside Kidney
Information network Recipe
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
**TOTAL FUNDS**|Incoming
resources
£
270,733
-
-
270,733
28,103
4,059
-
2
850
2,905
-
500
935
43
37,397
308,130|Resources
expended
£
(187,211)
-
(11,844)
(199,055)
(37,208)
(3,704)
(50,705)
-
-
-
(1,000)
-
-
(353)
(92,970)
(292,025)|Gains and
Movement
losses
in funds
£
£
319
83,841
(26,489)
(26,489)
-
(11,844)
(26,170)
45,508
-
(9,105)
-
355
-
(50,705)
-
2
-
850
-
2,905
-
(1,000)
-
500
-
935
-
(310)
-
(55,573)
(26,170)
(10,065)|
|---|---|---|---|
continued...
Page 18
**Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
## **14. MOVEMENT IN FUNDS - continued**
A current year 12 months and prior year 12 months combined position is as follows:
|**Unrestricted funds**
General fund
Revaluation Fund
Designated Fund
**Restricted funds**
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Polycystic kidney disease research
Cheshire and Merseyside Kidney
Information network Recipe
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
MRIKPA
**TOTAL FUNDS**|At 1.5.22
£
53,260
39,280
-
92,540
69,071
20,452
149,416
285
3,792
1,102
1,000
1,998
345
-
-
-
247,461
340,001|Net
movement
in funds
£
95,030
(23,890)
(31,274)
39,866
(18,643)
(1,269)
(50,705)
6
1,859
2,627
1,000
-
500
515
(81)
429
(63,762)
(23,896)|Transfers
between
funds
£
(40,571)
(1,310)
31,274
(10,607)
(10,000)
(837)
20,607
-
-
-
-
-
-
-
837
-
10,607
-|At
30.4.24
£
107,719
14,080
-|
|---|---|---|---|---|
|||||121,799
40,428
18,346
119,318
291
5,651
3,729
2,000
1,998
845
515
756
429|
|||||194,306|
|||||316,105|
continued...
Page 19
**Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
## **14. MOVEMENT IN FUNDS - continued**
A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:
|**Unrestricted funds**
General fund
Revaluation Fund
Designated Fund
**Restricted funds**
Children's Renal Fund
Bladder Exstrophy Fund
Grants Awarded Not Yet Taken
Kidney Info Network
Urology Sports Day
Tameside Dialysis
Adult Transplant Games
Cheshire and Merseyside Kidney
Information network Recipe
Altrincham Dialysis unit
Bladder Exstrophy Xmas Party
MRIKPA
**TOTAL FUNDS**|Incoming
resources
£
445,953
-
-
445,953
48,006
14,499
-
6
3,650
4,025
2,000
500
935
1,075
787
75,483
521,436|Resources
expended
£
(373,452)
-
(31,274)
(404,726)
(66,649)
(15,768)
(50,705)
-
(1,791)
(1,398)
(1,000)
-
(420)
(1,156)
(358)
(139,245)
(543,971)|Gains and
Movement
losses
in funds
£
£
22,529
95,030
(23,890)
(23,890)
-
(31,274)
(1,361)
39,866
-
(18,643)
-
(1,269)
-
(50,705)
-
6
-
1,859
-
2,627
-
1,000
-
500
-
515
-
(81)
-
429
-
(63,762)
(1,361)
(23,896)|
|---|---|---|---|
## **Purpose of funds**
## Designated Fund
The purpose of the designated funds is to provide for travel bursaries, upkeep of the renal library, small grants scheme and educational grants for renal staff and direct patient amenities.
## Revaluation Fund
The revaluation fund recognises the amount by which the investments exceed their historical cost.
## Bladder Exstrophy Fund
This fund is for use by the Bladder Exstrophy Team at Royal Manchester Children's Hospital to facilitate their annual Christmas Party, medical equipment and research funding.
## Children's Renal Fund (formerly Child Transplant Games)
This fund is for use by the Children's Renal Team at Royal Manchester Children's Hospital to facilitate the attendance of the Manchester Children's Transplant Games Team at the British Transplant Games each year, purchase of medical equipment, patient amenities for the wards and staff education.
continued...
Page 20
**Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
## **14. MOVEMENT IN FUNDS - continued**
## **Purpose of funds - continued**
## Kidney Info Network
We work with GMKIN (Greater Manchester Kidney Information Network) to provide a social media presence for kidney patients in the North West. The fund is for use in maintaining this presence.
## Tameside Dialysis Fund
Kidneys for Life received a donation in memory of a Tameside Dialysis patient and with the request that these funds be spent at Tameside Dialysis Unit. The staff at the Unit are aware of this donation and will communicate with Kidneys for Life when they decide how they would like this money to be spent.
## Urology Sports Day Fund
The Urology Sports Day was set up by Dr Anju Goyal and was paid for using funds from the Urology Fund which Kidneys for Life administers as per the MOU on their behalf. It is to be used to facilitate an annual event.
## Adult Games Fund
Kidneys for Life received a donation with the request that these funds be spent on adult games.
## Polycystic Kidney Disease Research Fund
Kidneys for Life received a donation with the request that these funds be spent on polycystic kidney disease research.
Cheshire and Merseyside Kidney Information Network Recipe Fund Received donations to fund a special renal recipe book.
## Altrincham Dialysis Fund
Kidneys for Life received a donation in memory of an Altrincham Dialysis patient and with the request that these funds be spent at this Unit. The staff at this Unit are aware of this donation and will communicate with Kidneys for Life when they decide how they would like this money to be spent.
## Bladder Exstrophy Xmas Party Fund
This is an annual event organised by the parents of the Bladder Ex fund. Kidneys for Life supports the parents in the organisation of this event. The money in this fund is used to pay for the party to take place.
## MRIKPA Fund
Kidneys for Life received a donation from the MRI Kidney Patient Association. This fund is to be used at the discretion of the Medical team on the Children's Renal Department at RMCH. The money is intended to be used for patients/caregivers for items that may improve efficiency of patient care. When access to funds is required, a member of the Medical team on the Children's Renal Department at RMCH completes a request form and this is reviewed by a second member of staff at RMCH, MRIKPA and a Kidneys for Life Trustee.
continued...
Page 21
**Kidneys For Life**
## **Notes to the Financial Statements - continued for the Year Ended 30 April 2024**
## **15. RELATED PARTY DISCLOSURES**
There were no related party transactions for the year ended 30 April 2024 and none for the year ended 30 April 2023.
All trustees remove themselves from any decision if they have a related party connection with the company being discussed.
## **16. FABRY NEPHROPATHY CONFERENCE FUND**
A separate bank account was opened to facilitate the income and expenditure for the bi-annual conference. The next conference is scheduled to take place in Hamburg in 2024. The movement on the account is shown below. The end balance equating to the balance on the bank account at the 30th April 2024.
||Balance at|||Balance at|
|---|---|---|---|---|
||1.5.23|Incoming|Outgoing|30.4.24|
||£|£|£|£|
|Movement to date|153,143|181,068|33,654|300,557|
||||||
The Fabry bank account owed £3,113 to Kidneys for life at the 30th April 2024.
The Fabry Fund is succeeding in its goal of maintaining reserves to at least the equivalent of a major sponsorship (£75,000).
The SCFUG, with Professor David Warnock & Professor Stephen Waldek at the helm, continue to ensure there are sufficient funds available before expenditure is approved thus ensuring there is never a shortfall of funds. The Fabry Fund is run by a proactive SCFUG who meet via Zoom on a regular basis. They are mindful of the financial position of the fund and as so agree that final decisions relating to travel bursaries are not to be made until sufficient educational grants from sponsors have been secured. This approach gives sufficient time to amend the program to fit within the budget.
Page 22
## **Kidneys For Life**
## **Detailed Statement of Financial Activities**
|**INCOME AND ENDOWMENTS**
**Donations and legacies**
Donations
Legacies
Grants
**Other trading activities**
Fundraising events
**Investment income**
Dividend and stock income
Deposit account interest
**Other income**
Other income
**Total incoming resources**
**EXPENDITURE**
**Raising donations and legacies**
Wages
Postage and miscellaneous
Promotional costs
Event costs
Travel costs
Card fees
Christmas cards
**Charitable activities**
Grant management
Bladder Exstrophy Fund
Children's Renal Fund (formerly Childrens
Transplant Games)
Miscellaneous grants
Ward and medical equipment
Travel & conference bursaries
Urology sports day
Small research grants
Nurse education
Carried forward|**for the Year Ended 30 April 2024**
30.4.24
30.4.23
£
£
109,106
134,150
26,625
-
4,000
4,627
139,731
138,777
68,744
164,632
2,920
2,720
918
518
3,838
3,238
993
1,483
213,306
308,130
45,990
38,280
1,224
1,826
13,876
14,269
13,769
72,437
1,994
1,010
3,252
906
2,080
2,631
82,185
131,359
20,216
17,808
1,003
1,947
23,166
27,195
2,007
8,513
-
1,254
5,331
2,574
1,594
-
57,740
50,705
5,057
2,054
116,114
112,050|**for the Year Ended 30 April 2024**
30.4.24
30.4.23
£
£
109,106
134,150
26,625
-
4,000
4,627
139,731
138,777
68,744
164,632
2,920
2,720
918
518
3,838
3,238
993
1,483
213,306
308,130
45,990
38,280
1,224
1,826
13,876
14,269
13,769
72,437
1,994
1,010
3,252
906
2,080
2,631
82,185
131,359
20,216
17,808
1,003
1,947
23,166
27,195
2,007
8,513
-
1,254
5,331
2,574
1,594
-
57,740
50,705
5,057
2,054
116,114
112,050|
|---|---|---|
|||138,777
164,632
2,720
518|
|||3,238
1,483|
|||308,130
38,280
1,826
14,269
72,437
1,010
906
2,631|
|||131,359
17,808
1,947
27,195
8,513
1,254
2,574
-
50,705
2,054
112,050|
This page does not form part of the statutory financial statements
Page 23
## **Kidneys For Life**
|**Detailed Statement of Financial Activities**|||
|---|---|---|
|**for the Year Ended 30 April 2024**|||
||30.4.24|30.4.23|
||£|£|
|**Charitable activities**|||
|Brought forward|116,114|112,050|
|Patient support|9,961|7,756|
|Publication grants|-|500|
||126,075|120,306|
|**Support costs**|||
|**Governance costs**|||
|Governance management|14,440|12,720|
|Insurance|612|608|
|Telephone|757|569|
|Accountancy|3,882|3,194|
|Investment management|2,586|2,053|
|Office Equipment & Computer Maintenance|||
|and Updates|17,901|21,216|
|Professional fees|3,508|-|
||43,686|40,360|
|Total resources expended|251,946|292,025|
|**Net (expenditure)/income before gains and**|||
|**losses**|(38,640)|16,105|
|**Realised recognised gains and losses**|||
|Realised gains/(losses) on fixed asset investments|22,210|319|
|Profit/(loss) on revaluation of investments|2,599|(26,489)|
|**Net expenditure**|(13,831)|(10,065)|
This page does not form part of the statutory financial statements
Page 24
**Signature**
## **Signature Certificate**
## Reference number: 3MSA4-6HYEL-QAVTI-LWZR9
## **Signer**
## **Timestamp**
## **Afshin Tavakoli**
Email: afshin.tavakoli@mft.nhs.uk
Sent: Viewed: Signed:
## **Recipient Verification:**
✔ Email verified
28 Jan 2025 15:40:42 UTC 28 Jan 2025 16:35:46 UTC 28 Jan 2025 16:37:18 UTC
28 Jan 2025 16:35:46 UTC
IP address: 86.141.151.29 Location: Stockport, United Kingdom
## **Amrit Kaur**
Email: amrit.kaur2@mft.nhs.uk
Sent: Viewed: Signed:
## **Recipient Verification:**
✔ Email verified
28 Jan 2025 15:40:42 UTC 29 Jan 2025 11:59:12 UTC 29 Jan 2025 12:38:12 UTC
29 Jan 2025 11:59:12 UTC
IP address: 109.149.165.240 Location: Sale, United Kingdom
Document completed by all parties on: 29 Jan 2025 13:12:45 UTC
Page 1 of 2
## **Signed with PandaDoc**
PandaDoc is a document workflow and certified eSignature solution trusted by 50,000+ companies worldwide.
## **Signature Certificate**
Reference number: 3MSA4-6HYEL-QAVTI-LWZR9
**Signer**
## **Timestamp**
## **Signature**
## **Paul Scriven**
Email: paulscriven@patersonbrodie.com
Sent: Viewed: Signed:
## **Recipient Verification:**
✔ Email verified
28 Jan 2025 15:40:42 UTC 29 Jan 2025 13:12:18 UTC 29 Jan 2025 13:12:45 UTC
29 Jan 2025 13:12:18 UTC
IP address: 94.30.103.138 Location: Stoke-on-Trent, United Kingdom
Document completed by all parties on: 29 Jan 2025 13:12:45 UTC
Page 2 of 2
## **Signed with PandaDoc**
PandaDoc is a document workflow and certified eSignature solution trusted by 50,000+ companies worldwide.